fibrinogen has been researched along with Liver Dysfunction in 235 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 154 (65.53) | 18.7374 |
| 1990's | 19 (8.09) | 18.2507 |
| 2000's | 20 (8.51) | 29.6817 |
| 2010's | 26 (11.06) | 24.3611 |
| 2020's | 16 (6.81) | 2.80 |
| Authors | Studies |
|---|---|
| Anser, H; Fatima, M; Fatima, S; Ikram, R; Munawwar, R; Sarfaraz, S | 1 |
| Alolga, RN; Liu, Q; Liu, XH; Qi, LW | 1 |
| Chen, L; Fang, Y; Li, XM; Wang, X; Wang, YZ; Wei, SM; Wu, X; Yin, JS | 1 |
| Boccatonda, A; Bucci, M; Cipollone, F; Cocco, G; D'Ardes, D; Fabiani, S; Guagnano, MT; Rossi, I; Schiavone, C | 1 |
| Flick, MJ; Francisco, BJ; Mullins, ES; Owens, AP; Palumbo, J; Rosenfeldt, L; Russell, HM; Sharma, BK | 1 |
| Ay, C; Buchtele, N; Egger, D; Grafeneder, J; Jilma, B; Schoergenhofer, C; Schwameis, M | 1 |
| Wagener, G | 1 |
| Chernyshenko, T; Chernyshenko, V; Gryshchenko, V; Hornytska, O; Klymenko, P; Korolova, D; Platonov, O; Platonova, T; Reshetnik, Y | 1 |
| Cox, S; Khamag, O; Millar, A; Numanoglu, A; Rode, H | 1 |
| Carrier, FM; Zaouter, C | 1 |
| Che, SL; Chen, L; Hou, XT; Li, F; Wang, L; Wang, WX; Yin, ZC; Zhang, H | 1 |
| Chen, L; Gan, Q; Gu, L; Liu, L; Liu, X; Wang, B | 1 |
| Han, M; Liu, C; Lu, S; Song, Y | 1 |
| Nishigami, T; Zen, Y | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Alessio, MG; Bonaffini, PA; Chun, HJ; Fernandez-Hernando, C; Hwa, J; Iwakiri, Y; Kawaguchi, N; Kondo, R; Lee, AI; Licini, L; McConnell, MJ; Pine, AB; Previtali, G; Price, C; Qing, H; Seghezzi, M; Sironi, S; Sonzogni, A; Strazzabosco, M; Sun, Z; Utsumi, T; Valle, C; Wang, A; Zhang, X | 1 |
| Beltran, J; Blasi, A; Costa, M; Reyes, R; Sabate, A; Torres, F | 1 |
| Akyol, G; Al-Hussaini, A; Bartuli, A; Bellacchio, E; Boldrini, R; Callea, F; Dalgic, B; Francalanci, P; Giovannoni, I; Guldal, E; Maggiore, G; Sari, S; Sogo, T | 1 |
| Azzopardi, N; Ellul, P; Gatt, A; Gatt, P; Gerada, J; Grima, C; Inguanez, MB; Pocock, J; Rizzo, K; Vassallo, M; Vella, K; Zammit, D | 1 |
| Adelmeijer, J; Groeneveld, D; Kopec, AK; Lisman, T; Luyendyk, JP; Ottens, P; Pereyra, D; Starlinger, P; Veldhuis, Z | 1 |
| Banerjee, A; Girish, A; Hickman, DA; Huang, S; Luc, N; Ma, Y; Miyazawa, K; Sekhon, UDS; Sen Gupta, A; Sun, M | 1 |
| Ávila, MA; Banales, JM; Berasain, C; Carotti, S; Elizalde, M; Fernández-Barrena, MG; Garcia-Irigoyen, O; Latasa, MU; Morini, S; Orbe, J; Páramo, JA; Parks, WC; Prieto, J; Rodriguez, JA; Uriarte, I; Urtasun, R; Vespasiani-Gentilucci, U | 1 |
| Dirkmann, D; Görlinger, K; Hartmann, M; Kirchner, C; Paul, A; Saner, FH; Treckmann, JW | 1 |
| Argo, CK; Caldwell, SH; Intagliata, NM; Northup, PG; Shah, NL | 1 |
| Casals, G; Crespo, G; Forns, X; Jiménez, W; Marfà, S; Morales-Ruiz, M; Navasa, M; Reichenbach, V | 1 |
| Casini, A; de Moerloose, P; Lukowski, SW; Lurz, E; Neerman-Arbez, M; Rieubland, C; Sokollik, C | 1 |
| Asselta, R; Braidotti, P; Caccia, S; D'Antiga, L; Duga, S; Maggiore, G; Nastasio, S; Perisic, VN; Peyvandi, F; Robusto, M | 1 |
| Lippi, G; Plebani, M; Tripodi, A | 1 |
| Acosta, F; Beltran, J; Blasi, A; Costa, M; Gutierrez, R; Mellado, P; Reyes, R; Sabate, A; Torres, F | 1 |
| Kopec, AK; Luyendyk, JP | 1 |
| Arai, S; Honda, T; Mukai, S; Ogiwara, N; Okumura, N; Sugano, M; Takezawa, Y | 1 |
| Olu-Eddo, AN; Omoti, CE; Omuemu, CE | 1 |
| Briceño, J; Ciria, R; Díaz-Nieto, R; López-Cillero, P; Luque, A; Naranjo, A; Rufián, S; Sánchez-Hidalgo, JM | 1 |
| Brennan, SO; Conard, K; Davis, RL; Furuya, KN; Savo, A | 1 |
| FREEMAN, S; RHOADS, PS; YEAGER, LB | 1 |
| Hollensead, SC; Math, SK; Sanders, MA | 1 |
| Airò Farulla, C; Cipolla, C; Ferro, G; Galia, M; Giannitrapani, L; Graceffa, G; Latteri, MA; Lodato, L; Lombardo, G; Sandonato, L | 1 |
| Ahmed, M; Ghani, MH; Ghori, MA; Memon, MA; Mustafa, G; Siddiqui, SA | 1 |
| Heaton, N; Millar, AJ; Mirza, D; Rela, M; Sharif, K; Vilca-Melendez, H | 1 |
| Amer, A; Jacob, M; Kei-Hui, D; Manas, D; Robinson, S; Saif, R; Sen, G; White, S | 1 |
| Li, B; Li, C; Mi, K; Wang, WT; Wei, YG; Wen, TF; Xu, MQ; Yan, LN; Yang, JY | 1 |
| Doi, M; Hagisawa, K; Handa, M; Iwaya, K; Katsuno, S; Kinoshita, M; Nishikawa, K; Saitoh, D; Sakamoto, T; Seki, S; Shono, S; Suzuki, H; Takeoka, S; Yanagawa, R | 1 |
| Hall, DP; Lone, NI; Stanworth, SJ; Walsh, TS; Watson, DM | 1 |
| Darwish Murad, S; de Maat, MP; García-Pagán, JC; Janssen, HL; Koehler, E; Leebeek, FW; Plessier, A; Primignani, M; Rijken, DC; Seijo, S; Smalberg, JH; Trebicka, J; Valla, DC | 1 |
| Kim, HK; Song, JW; Song, KS | 1 |
| Betts, CM; Dal Monte, PR; Foschini, MP; Macchia, S; Marucci, G; Morandi, L; Pession, A; Tardio, ML | 1 |
| FIELD, JB; LARSEN, EG | 1 |
| BEVACQUA, V; VILLA, AM | 1 |
| FRIMBERGER, F | 1 |
| OLSZEWSKI, W | 1 |
| BOLANDRINA, E; SOARDI, F | 1 |
| OGIWARA, Y | 1 |
| HALLEN, A; NILSSON, IM | 1 |
| SONODA, N | 1 |
| Csete, M; Levy, JH; Quach, T; Szlam, F; Tippens, M; Van Dyke, R | 1 |
| BEAN, WB; de la HUERGA, J; FRANKLIN, M; PAUL, WD; POPPER, H; ROUTH, JI | 1 |
| Hiura, H | 1 |
| Asselta, R; Braidotti, P; Coggi, G; Duga, S; Maggioni, M; Malcovati, M; Pellegrini, C; Santagostino, E; Tenchini, ML | 1 |
| Brennan, SO; Crum, BE; Dear, A; George, PM; Kaltenbrun, ER; Kruse, KB; McCracken, AA | 1 |
| den Boer, MA; Havekes, LM; Korsheninnikova, E; Kuipers, F; Ouwens, DM; Romijn, JA; Schröder-van der Elst, JP; Voshol, PJ | 1 |
| Ostermann, H | 1 |
| Cho, HI; Kang, SH; Kim, HK; Kim, JQ; Lee, DS; Park, S | 1 |
| Chen, ZN; Han, Y; Hu, S; Li, Y; Liu, G; Song, Q; Song, Y; Tao, Y; Wang, J; Wang, L; Wu, L; Yang, H; Yao, X; Zeng, H; Zhang, Y; Zhu, H | 1 |
| Calès, P; De Mazancourt, P; Dib, N; Hanss, M; Michalak, S; Quelin, F; Rousselet, MC; Ternisien, C | 1 |
| Inoue, K; Satoh, M; Takano, H | 1 |
| Bartos, V; Brzek, V; Chrobák, L; Hnízdová, D | 1 |
| Applebaum, J; Castleman, L; Elguezabal, A; Fine, NL | 1 |
| Bell, WR; Reiner, AP | 1 |
| Itakura, M; Iwamura, K; Kamiguchi, H; Katsunuma, T; Matsuzaki, S | 1 |
| Bakalova, R; Boiadzhiian, Kh | 1 |
| Armstrong, DJ; Francis, JL | 3 |
| Bontempo, FA; Lewis, JH; Ragni, MV; Spero, JA | 1 |
| Triplett, DA | 1 |
| Gilman, PB; Keane, PM; Martinez, J; Palascak, JE | 1 |
| Mackie, MJ; McVerry, BA; Reilly, JT | 1 |
| de Vos, R; de Wolf-Peeters, C; Desmet, VJ; Vanstapel, MJ | 1 |
| Francis, JL; Simmonds, VJ; Watson, NJ | 1 |
| Kevorkov, NN; Tsimmerman, IaS; Vorona, TV | 1 |
| Marengo-Rowe, AJ | 1 |
| MacDonald, KA; Martinez, J; Palascak, JE | 1 |
| Federici, AB; Mannucci, PM; Sirchia, G | 1 |
| Carrell, NA; Cooper, HA; Hoots, WK; McDonagh, J; Wagner, RH | 1 |
| Barnes, T; Halle, P; Hoefs, J | 1 |
| Lorand, L; Losowsky, MS; Miloszewski, KJ | 1 |
| Brusoni, V; Perego, M; Scotti, A; Turpini, R | 1 |
| Ansley, JD; Henderson, JM; Kutner, M; Rudman, D; Stein, SF; Wiles, MB | 1 |
| Cantoni, L; Carelli, M; Ghezzi, P; Sironi, M; van der Meer, JW; Vogels, MT | 1 |
| Budzynski, AZ; Doyle, CJ; Tan, V | 1 |
| Clayton, DG; Kramer, DJ; Miro, AM; Rodman, N; Wearden, S | 1 |
| Armbrust, T; Knittel, T; Neubauer, K; Ramadori, G | 1 |
| Billiar, TR; Di Silvio, M; Geller, DA; Kispert, PH; Simmons, RL; Su, GL; Tweardy, DJ; Wang, SC | 1 |
| Engelbrecht, G; Hickman, R; Jaskiewicz, K; Kahn, D; Kirsch, RE; Robson, SC | 1 |
| De Craemer, D; Pipeleers-Marichal, M; van den Branden, C; Vandenplas, Y | 1 |
| Bailie, MB; Fink, GD; Pearson, JM; Roth, RA | 1 |
| Chujo, M; Nakamura, K; Shibatani, M; Suzuki, T | 1 |
| Ikeda, Y; Ishida, A; Mori, T; Murata, M; Muto, A; Okamoto, S; Tanosaki, R; Wakui, M | 1 |
| Eramishantsev, AK; Movchun, AA; Shatverian, GA; Skipenko, OG | 1 |
| Bacher, H; Cerwenka, H; El-Shabrawi, A; Mischinger, HJ; Werkgartner, G | 1 |
| Lawrie, AS; Machin, SJ; Mackie, IJ; McDonald, SJ; Purdy, G | 1 |
| Ikeda, Y; Mori, T | 1 |
| Montes, R; Panizo, C; Páramo, JA; Rocha, E | 1 |
| Falkenhagen, D; Gerner, FJ; Linsberger, I; Schoenhofen, M; Schrefl, A; Strobl, W; Vogt, G | 1 |
| Suhr, OB | 1 |
| Booth, DR; Gillmore, JD; Hawkins, PN; Heaton, ND; Pepys, MB; Rahman, V; Rela, M; Stangou, AJ | 1 |
| Andrews, JL; Cameron, C; Connelly, S; Gallo-Penn, AM; Hough, C; Kaleko, M; Lillicrap, D; Notley, C; Shirley, PS; Tinlin, S; Webster, S | 1 |
| Boelens, PG; Borel Rinkes, IH; Cuesta, MA; Gouma, DJ; Hack, CE; Meijer, C; Meijer, S; Nijveldt, RJ; Scotté, M; Statius Muller, MG; Thijs, LG; Tilanus, HW; van de Velde, CJ; van Leeuwen, PA; Wedel, NI; Wiezer, MJ; Wiggers, T; Zoetmulder, FA | 1 |
| Brennan, SO; Callea, F; Fabbretti, G; George, PM; Kudryk, B; Medicina, D | 1 |
| Borawski, J; Myśliwiec, M | 1 |
| Dechavanne, M; Ffrench, P; Hanss, M; Négrier, C; Sobas, F; Trzeciak, MC | 1 |
| Dymock, IW; Green, G; Poller, L; Thomson, JM | 4 |
| Bugat, R; Duffaut, M; Mignon-Conte, M; Orfila, C; Rumeau, JL; Suc, JM | 1 |
| Lechner, K; Niessner, H; Thaler, E | 1 |
| Morikawa, M; Shimano, N; Uete, T | 1 |
| Hasiba, U; Lewis, JH; Spero, JA | 1 |
| Shaw, ST | 1 |
| Straub, PW | 2 |
| Boggian, O; Coccheri, S; Dalmonte, PR; Palareti, G; Poggi, M | 1 |
| Flute, PT | 1 |
| Gurewich, V; Lipinska, I; Lipinski, B; Nowak, A | 1 |
| Ebeling, H | 1 |
| Kwasniak, D; Martinez, J; Palascak, JE | 1 |
| Allardyce, M; Barr, RD; Brunt, PW; McPhie, JL | 1 |
| Lipiński, B | 1 |
| Barr, RD | 1 |
| Kleinberger, G; Kotzaurek, R; Lechner, K; Pall, H; Pichler, M | 1 |
| Frezza, M; Gilotta, S; Milani, S; Nicolini, R; Pozzato, G; Valente, G | 1 |
| Kakkar, VV; Lane, DA; Scully, MF; Thomas, DP; Williams, R; Woolf, IL | 1 |
| Martinez, J; Palascak, JE | 1 |
| Kakkar, VV; Lane, DA; Scully, MF | 1 |
| Olszańska-Skorek, T | 1 |
| Al-Mondhiry, H | 1 |
| Bloom, AL | 1 |
| López Borrasca, A; Marín, J; Ortega, J; Rocha, E | 1 |
| Kochen, M; Leonhardt, H; Palme, G | 1 |
| Fine, J | 1 |
| Brunswig, D; Grün, M; Liehr, H; Rasenack, U; Thiel, H | 1 |
| Wilson, JG | 1 |
| Kasper, CK | 1 |
| Dymock, IW; Poller, L; Thomson, JM; Tucker, JS; Woolf, IL | 1 |
| Hule, V | 1 |
| Langley, PG; Williams, R | 1 |
| Niwano, H; Shibata, A; Takahashi, H; Tatewaki, W; Wada, K | 1 |
| Dietze, H; Maak, B; Meyer, M | 1 |
| Niizuma, H; Otsuki, T; Suzuki, J; Yonemitsu, T | 1 |
| Conlan, MG; Mosher, DF; Schultz, RL; Tomasini, BR | 1 |
| Allardyce, M; Barr, RD; Brunt, PW; McIntire, KR; Usher, DJ | 1 |
| Williams, EC | 1 |
| Lai, EC; Ng, IO; Ng, M; Wu, PC | 1 |
| Aronson, D; Carr, JM; McDonagh, J; vanDeWater, L | 1 |
| Kelly, DA; Tuddenham, EG | 1 |
| Blick, KE; Chang, A; D'Angelo, A; Esmon, CT; Taylor, FB; Vigano-D'Angelo, S | 1 |
| Farias, C; Frontroth, JP; Kempfer, AC; Lazzari, M; Patrao de Macedo, M | 1 |
| Grundmann, R; Koebe, HG; Waters, W | 1 |
| Lane, DA; Southan, C; Thompson, E | 1 |
| Boks, AL; Bruinvels, J; de Groot, GH; Jeekel, H; Reuvers, CB; Schalm, SW; ten Kate, FW; Terpstra, OT | 1 |
| Malchesky, PS; Nose, Y; Okabe, K; Sakamoto, H; Smith, JW; Takaoka, T; Tuthill, RJ; Usami, M | 1 |
| Ronneberger, H | 1 |
| Corrigan, JJ; Lox, CD; Word, RA | 1 |
| Higuchi, A | 1 |
| Boiadzhiian, KhP | 1 |
| Accinni, L; Andres, GA; Ansell, ID; Calne, RY; Halgrimson, CG; Herbertson, BM; Hsu, KC; Penn, I; Porter, KA; Rendall, JM; Starzl, TE; Williams, R | 1 |
| Soulier, JP | 1 |
| Kotschy, M | 1 |
| Gordon, AH; Koj, A | 1 |
| Fukuda, T; Hirayama, C; Murai, N | 1 |
| Becker, W; Rapp, W; Schwick, HG; Störiko, K | 1 |
| Schmitt, H | 1 |
| Flute, PT; Pannell, G; Rake, MO; Williams, R | 1 |
| Egli, H | 1 |
| Hardaway, RM | 1 |
| DeGroot, JJ; Horney, FD; McSherry, BJ | 1 |
| Ansari, A; Silvis, SE | 1 |
| Aiach, M; Busy, MF; Chanrion, C; Durand, H; Guéroult, N; Justin-Besançon, L; Leclerc, M; Rogé, J | 1 |
| Wardle, EN | 1 |
| Ash, G; Bidwell, E; Gazzard, BG; Lewis, ML; Rizza, CR; Williams, R | 1 |
| Hillenbrand, P; Jedrychowski, A; Parbhoo, SP; Sherlock, S | 2 |
| Clark, R; Flute, PT; Rake, MO; Williams, R | 1 |
| Kreuning, J; Veltkamp, JJ | 1 |
| Kwaan, HC | 1 |
| Colman, RW; Minna, JD; Robboy, SJ | 1 |
| Nemerson, Y | 1 |
| Czapek, EE | 1 |
| Rö, JS | 1 |
| Collen, D; Vermylen, J; Verstraete, M | 1 |
| Lasch, HG | 1 |
| Niculescu-Zinca, D; Răiciulescu, N; Stoichiţă-Papilian, M | 1 |
| Hedner, U; Nilsson, IM | 1 |
| Matsuda, T | 1 |
| Larmi, TK | 1 |
| Hayne, OA; Sherman, LA | 1 |
| Hirsh, J; Luke, KH; Mant, MJ; Pineo, GF | 1 |
| Flute, PT; Pannell, G; Rake, MO; Shilkin, KB; Williams, R | 1 |
| Bennett, BB; Bueffel, B; Corrigan, JJ | 1 |
| Borirakchanyavat, V; Clark, R; Flute, PT; Gazzard, BG; Rake, MO; Shilkin, KB; Williams, R | 1 |
| Kourilsky, O; Leroy, C; Peltier, AP | 1 |
| Astedt, B; Hedner, U; Svanberg, L | 1 |
| Eldor, A; Eyal, F; Russell, A; Yatziv, S | 1 |
| Hampton, JW | 1 |
| Engstrom, AW | 1 |
| Aster, RH; Ginsburg, AD | 1 |
| Wardle, EN; Wright, NA | 1 |
| Nilsson, IM | 1 |
| Coon, WW; Iob, VL | 1 |
| Niléhn, JE | 1 |
| Gans, H; Mori, K; Quinlan, R; Richter, D; Tan, BH | 1 |
| Hedner, U; Nilsson, M | 1 |
| Collen, D; Oei, LS; Tytgat, GN; Van Damme, B | 1 |
| Fleisher, R; Hague, R; Kolthammer, J; Shilkin, KB; Williams, R; Winch, J | 1 |
| Black, JM; Garvey, MB | 1 |
| Winch, J | 1 |
| Bentley, P; Fleisher, R; Hague, R; Kolthammer, J; Shilkin, KB; Williams, R; Winch, J | 1 |
| Pudlák, P | 1 |
| Flute, PT; Rake, MO; Shilkin, KB; Williams, R | 1 |
| Beck, EA | 1 |
| Coodley, EL | 1 |
| Bowie, EJ; Didisheim, P; Oels, HC; Owen, CA; Thompson, JH | 1 |
| Grannis, GF | 1 |
| Brodonova, M; Escartin, P; Flute, PT; Rake, MO; Williams, R | 1 |
| Brodsky, I; Kahn, SB; Petkov, G; Ross, EM; Siegel, NH | 1 |
| Frick, PG; Meili, EO; Straub, PW | 1 |
| Schalm, OW | 1 |
| Dineen, PA; Gans, H; Kaster, B; Lindsey, E; Mori, K; Quinlan, R; Richter, D; Tan, BH | 1 |
| Losowsky, MS; Walls, WD | 2 |
| Gugler, E; Tschäppeler, H | 1 |
| Yamada, K; Yamada, Z | 1 |
| Allgén, LG | 1 |
37 review(s) available for fibrinogen and Liver Dysfunction
| Article | Year |
|---|---|
Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.
Topics: Biomarkers, Tumor; Fibrinogen; Humans; Immunotherapy; Liver Diseases; Metabolic Diseases; Neoplasms | 2022 |
[Clinicopathological features of hepatic fibrinogen storage disease in children].
Topics: Child; Child, Preschool; China; Female; Fibrinogen; Humans; Liver; Liver Diseases; Male; Metabolic Diseases; Retrospective Studies | 2022 |
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
Topics: Blood Coagulation Disorders; COVID-19; Fibrinogen; Humans; Liver Diseases; SARS-CoV-2; Thrombosis | 2022 |
Rethinking fibrinogen storage disease of the liver: ground glass and globular inclusions do not represent a congenital metabolic disorder but acquired collective retention of proteins.
Topics: Adult; Biomarkers; Biopsy; C-Reactive Protein; Complement C4b; Female; Fibrinogen; Humans; Immunohistochemistry; Inclusion Bodies; Liver; Liver Diseases; Male; Metabolism, Inborn Errors; Middle Aged; Peptide Fragments; Terminology as Topic | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Procoagulant therapeutics in liver disease: a critique and clinical rationale.
Topics: Antifibrinolytic Agents; Coagulants; Deamino Arginine Vasopressin; Erythrocyte Transfusion; Factor VIIa; Factor VIII; Fibrinogen; Hemorrhage; Humans; Liver Diseases; Plasma; Recombinant Proteins; Vitamin K | 2014 |
Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Fibrin; Fibrinogen; Humans; Liver Diseases; Mice | 2016 |
Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.
Topics: Administration, Topical; Biocompatible Materials; Blood Loss, Surgical; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Hemostatic Techniques; Hemostatics; Hepatectomy; Humans; Laparoscopy; Liver Diseases; Surgical Sponges; Thrombin; Treatment Outcome | 2011 |
[Fibrinogen (factor I) and dys (functional) -fibrinogen].
Topics: Afibrinogenemia; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhagic Disorders; Humans; Liver Diseases; Neoplasms; Reference Values; Severity of Illness Index; Thrombophilia | 2004 |
[Coagulation failure: diagnosis, management and therapeutic consequences].
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Liver Diseases | 2006 |
The fibrinolytic system in man.
Topics: alpha 1-Antitrypsin; alpha-2-Antiplasmin; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Arterial Occlusive Diseases; Arteriosclerosis; Complement C1 Inactivator Proteins; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Kidney Diseases; Liver Diseases; Myocardial Infarction; Neoplasms; Plasminogen; Pulmonary Embolism; Thrombophlebitis | 1984 |
Acquired dysfibrinogenaemia.
Topics: Adult; Blood Coagulation Disorders; Fibrin; Fibrinogen; Humans; Infant, Newborn; Infant, Newborn, Diseases; Liver Diseases; Protein Conformation; Sialic Acids | 1983 |
New methods in coagulation.
Topics: beta-Thromboglobulin; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Chromogenic Compounds; Factor IX; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinopeptide A; Genetic Variation; Humans; Immunologic Techniques; Liver Diseases; Platelet Factor 4; Prothrombin | 1981 |
Approach to the bleeding patient.
Topics: Anticoagulants; Blood Group Antigens; Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Extracorporeal Circulation; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Intraoperative Period; Leukocytes; Liver Diseases; Plasma; Platelet Transfusion; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Transfusion Reaction; Vitamin K Deficiency | 1982 |
[Acquired dysfibrinogenemia].
Topics: Afibrinogenemia; Antineoplastic Agents; Biomarkers; Bone Marrow Transplantation; Fibrinogen; Humans; Liver Diseases; Thrombin Time | 1998 |
Acute generalized, widespread bleeding. Diagnosis and management.
Topics: Acute Disease; Algorithms; Antibodies, Monoclonal; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Contraindications; Cytokines; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematologic Diseases; Hemorrhage; Heparin; Humans; Infections; Liver Diseases; Neoplasms; Plasma; Platelet Transfusion; Thrombophilia | 1998 |
[Transplantation for amyloidosis].
Topics: Amyloidosis; Apolipoproteins A; Cardiomyopathies; Dialysis; Fibrinogen; Humans; Kidney Diseases; Liver Diseases; Muramidase; Organ Transplantation; Prealbumin | 2000 |
Coagulopathies.
Topics: Afibrinogenemia; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Factor VIII; Factor XI Deficiency; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemophilia A; Hemophilia B; Hemostasis; Humans; Hypoprothrombinemias; Kininogens; Liver Diseases; Prekallikrein; Vitamin K Deficiency; von Willebrand Diseases | 1977 |
Assays for fibrinogen and its derivatives.
Topics: Adult; Afibrinogenemia; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Chemical Phenomena; Chemistry; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Humans; Infant, Newborn; Kidney Diseases; Liver Diseases; Male; Models, Biological; Pregnancy | 1977 |
Diffuse intravascular coagulation in liver disease?
Topics: Afibrinogenemia; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Factor V Deficiency; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Half-Life; Hemophilia A; Heparin; Humans; Liver Diseases; Peptide Hydrolases; Thrombocytopenia; Thrombosis | 1977 |
Clotting abnormalities in liver disease.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Female; Fibrinogen; Humans; Liver Diseases; Pregnancy; Prognosis | 1979 |
[Quantitative plasma protein determination as an aid to diagnosis (author's transl)].
Topics: Acute Disease; Blood Proteins; Ceruloplasmin; Complement C3; Diagnosis, Differential; Fibrinogen; Humans; Inflammation; Liver Diseases; Methods; Serum Albumin; Transferrin | 1977 |
Intravascular coagulation and the liver.
Topics: Acute Disease; Chronic Disease; Erythrocyte Aggregation; Factor VIII; Fibrinogen; Heparin; Humans; Liver Diseases; Liver Extracts | 1975 |
Haemostatic problems in liver disease.
Topics: Blood Coagulation; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Factor VIII; Fibrinogen; Hemostasis; Humans; Liver; Liver Diseases; Prognosis; Risk; Vitamin K | 1986 |
[Liver diseases and serum proteins].
Topics: Blood Protein Electrophoresis; Blood Proteins; Fibrinogen; gamma-Globulins; Glycoproteins; Humans; Lipoproteins; Liver Diseases; Serum Albumin | 1968 |
Coagulation disorders and hemorrhagic shock in the parturient.
Topics: Abruptio Placentae; Acute Kidney Injury; Blood Coagulation Disorders; Blood Transfusion; Embolism, Amniotic Fluid; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hydatidiform Mole; Liver Diseases; Necrosis; Obstetric Labor Complications; Oxygen Inhalation Therapy; Parenteral Nutrition; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Sepsis; Shock, Hemorrhagic; Thrombophlebitis; Vasodilator Agents | 1968 |
Plasma fibrinogen levels in normal and sick cows.
Topics: Abomasum; Abscess; Animals; Cattle; Cattle Diseases; Diarrhea; Dogs; Female; Fibrinogen; Horses; Humans; Joint Dislocations; Liver Diseases; Lymphoma, Non-Hodgkin; Male; Mastitis, Bovine; Nephritis; Nutrition Disorders; Pericarditis; Peritonitis; Pneumonia; Pregnancy; Pregnancy, Animal; Rupture; Urinary Bladder; Virus Diseases | 1970 |
Disorders of fibrinolysis.
Topics: Afibrinogenemia; Aminocaproates; Antifibrinolytic Agents; Autoimmune Diseases; Blood Coagulation Disorders; Blood Platelets; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Leukemia; Liver Diseases; Plasminogen; Prothrombin Time; Surgical Procedures, Operative | 1972 |
Disseminated intravascular coagulation (DIC): an approach.
Topics: Anemia, Hemolytic; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Factor XII; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Diseases; Meningitis, Meningococcal; Phospholipids; Thrombin; Thromboplastin | 1972 |
Diagnosis of hemorrhagic disorders.
Topics: Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Calcium; Factor IX; Factor V; Factor VIII; Factor X; Factor XII; Fibrin; Fibrinogen; Humans; Liver Diseases; Phospholipids; Prothrombin; Prothrombin Time; Thromboplastin; Vitamin K Deficiency | 1973 |
Coagulation problems.
Topics: Abruptio Placentae; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Transfusion; Disseminated Intravascular Coagulation; Embolism, Amniotic Fluid; Factor XIII Deficiency; Female; Fetal Death; Fetal Diseases; Fibrin; Fibrinogen; Fibrinolysis; Hemophilia A; Humans; Liver Diseases; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Sepsis; Uterine Hemorrhage; Vitamin K | 1973 |
Hemostatic problems in liver surgery.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Dogs; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Postoperative Complications; Prothrombin; Vitamin K Deficiency | 1973 |
Intravascular coagulation in liver disease.
Topics: Animals; Blood Coagulation Factors; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Half-Life; Hemostasis; Humans; Ligation; Liver; Liver Cirrhosis; Liver Diseases; Plasminogen; Portal Vein; Prothrombin | 1974 |
[The liver and plasma coagulation factors. Pathophysiology].
Topics: Antithrombins; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Cholestasis; Disseminated Intravascular Coagulation; Esophageal and Gastric Varices; Factor IX; Factor V; Factor VIII; Factor XIII; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Microcirculation; Transplantation, Homologous | 1973 |
Factor 8: a review.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Calcium; Enzyme Induction; Factor XIII; Fibrinogen; Humans; Liver Diseases; Poisoning | 1968 |
Platelet function: its clinical significance.
Topics: Adenine Nucleotides; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Clot Retraction; Collagen; Fibrin; Fibrinogen; Hemostasis; Kidney Diseases; Liver Diseases; Platelet Adhesiveness; Thrombocytopenia; Thrombocytosis | 1970 |
The liver and protein metabolism.
Topics: Amino Acids; Blood Proteins; Chemical and Drug Induced Liver Injury; Cystine; Diet Therapy; Dietary Proteins; Fatty Liver; Fibrinogen; Flocculation Tests; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Necrosis; Protein Biosynthesis; Protein Deficiency; Proteins; Prothrombin Time; RNA; Serum Albumin; Serum Globulins; Thyroid Hormones | 1964 |
7 trial(s) available for fibrinogen and Liver Dysfunction
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Models, Biological; Thrombelastography | 2019 |
Impact of Preemptive Fibrinogen Concentrate on Transfusion Requirements in Liver Transplantation: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Aged; Blood Loss, Surgical; Blood Transfusion; Double-Blind Method; Female; Fibrinogen; Follow-Up Studies; Hemostatics; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prognosis | 2016 |
A prospective study of the efficacy of clinical application of a new carrier-bound fibrin sealant after liver resection.
Topics: Adult; Aged; Blood Transfusion; Drainage; Drug Carriers; Drug Combinations; Female; Fibrinogen; Hemostasis, Surgical; Hepatectomy; Humans; Length of Stay; Liver Diseases; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Thrombin; Treatment Outcome | 2010 |
The use of TachoSil in children undergoing liver resection with or without segmental liver transplantation.
Topics: Blood Loss, Surgical; Child; Child, Preschool; Drug Combinations; Fibrinogen; Follow-Up Studies; Hemostasis, Surgical; Hepatectomy; Humans; Infant; Infant, Newborn; Liver Diseases; Liver Transplantation; Prospective Studies; Surgical Sponges; Thrombin; Treatment Outcome | 2011 |
Coagulopathy following major liver resection: the effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver.
Topics: Abdomen; Adult; Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antithrombin III; Bacterial Translocation; Bilirubin; Biomarkers; Blood Coagulation Factors; Comorbidity; Complement C1 Inactivator Proteins; Disseminated Intravascular Coagulation; Double-Blind Method; Endotoxemia; Endotoxins; Female; Fibrinogen; Fibrinolysis; Gastrointestinal Neoplasms; Hepatectomy; Humans; Immunoglobulin G; Interleukin-6; Kupffer Cells; Liver; Liver Diseases; Liver Failure; Male; Membrane Proteins; Middle Aged; Peptide Hydrolases; Plasminogen; Postoperative Period; Prospective Studies; Sepsis; Tissue Plasminogen Activator | 2001 |
Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
Topics: Acute Disease; Adult; Bilirubin; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Factor IX; Factor X; Factor XIII; Fibrinogen; Hemorrhagic Disorders; Heparin; Humans; Infusions, Parenteral; Liver Diseases; Middle Aged; Prothrombin | 1974 |
192 other study(ies) available for fibrinogen and Liver Dysfunction
| Article | Year |
|---|---|
Evaluation of Hepatoprotective effects of different doses of Lyophilized Beetroot powder in albino rabbits.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Beta vulgaris; Blood Coagulation; Dietary Supplements; Dose-Response Relationship, Drug; Fibrinogen; Freeze Drying; Liver; Liver Diseases; Liver Function Tests; Plant Roots; Powders; Protective Agents; Prothrombin Time; Rabbits | 2021 |
Pediatric patient with fibrinogen Villeurbanne II presenting with an unprovoked portal vein thrombosis.
Topics: Child; Fibrinogen; Humans; Liver Diseases; Portal Vein; Venous Thrombosis | 2022 |
Disseminated Intravascular Coagulation Score Predicts Mortality in Patients with Liver Disease and Low Fibrinogen Level.
Topics: Afibrinogenemia; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Retrospective Studies | 2022 |
The Supply Side of Coagulation: Fibrinogen and Bleeding in Liver Disease and Transplantation.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Liver Diseases | 2023 |
Blood coagulation factors and platelet response to drug-induced hepatitis and hepatosis in rats.
Topics: Animals; Blood Coagulation Factors; Chemical and Drug Induced Liver Injury; Factor X; Fibrinogen; Hemostatics; Liver Diseases; Prothrombin; Rats | 2023 |
Surgical management of extrahepatic portal vein obstruction in children: advantages of MesoRex shunt compared with distal splenorenal shunt.
Topics: Adolescent; Child; Child, Preschool; Esophageal and Gastric Varices; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Infant; Infant, Newborn; Liver Diseases; Portal Vein; Portasystemic Shunt, Surgical; Splenorenal Shunt, Surgical; Varicose Veins | 2023 |
Comment on: "The Supply Side of Coagulation: Fibrinogen and Bleeding in Liver Disease and Transplantation." The Known, the Unknown, the Possibly Known, and the Impossible.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Liver Diseases | 2023 |
[Hepatic fibrinogen storage disease: a clinicopathological analysis of two cases].
Topics: Fibrinogen; Humans; Liver; Liver Diseases; Metabolic Diseases | 2023 |
Hepatic fibrinogen storage disease and hypofibrinogenemia caused by fibrinogen Aguadilla mutation: a case report.
Topics: Afibrinogenemia; Child, Preschool; Endoplasmic Reticulum; Eosinophils; Fibrinogen; Humans; Inclusion Bodies; Liver; Liver Diseases; Male; Mutation, Missense; Polymorphism, Single Nucleotide | 2020 |
Hemocoagulase agkistrodon can prevent bleeding and induce hypofibrinogenemia in hepatic disease cases
.
Topics: Afibrinogenemia; Agkistrodon; Animals; Batroxobin; Fibrinogen; Hemostatics; Humans; Liver Diseases | 2020 |
Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.
Topics: Adult; Blood Coagulation Disorders; COVID-19; Endothelial Cells; Fibrinogen; Humans; Interleukin-6; Janus Kinase 1; Liver Diseases; Nitriles; Pyrazoles; Pyrimidines; Retrospective Studies; SARS-CoV-2; Signal Transduction; STAT3 Transcription Factor; von Willebrand Factor | 2021 |
Correlation between plasma fibrinogen and FIBTEM thromboelastometry during liver transplantation: a comprehensive assessment.
Topics: Blood Coagulation; Double-Blind Method; Erythrocyte Transfusion; Female; Fibrinogen; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Platelet Count; Thrombelastography | 2017 |
Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage.
Topics: Afibrinogenemia; Apolipoprotein B-100; Child, Preschool; Endoplasmic Reticulum; Female; Fibrinogen; Hepatocytes; Humans; Hypolipoproteinemias; Liver; Liver Diseases; Male; Middle Aged; Mutation; Protein Conformation; Structure-Activity Relationship | 2017 |
Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Blood Coagulation; Female; Fibrinogen; Follow-Up Studies; Hepatectomy; Humans; Liver Diseases; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Middle Aged; Platelet Activation; Prognosis; Prospective Studies; Receptors, Thrombin; Thrombin; Thromboplastin | 2019 |
Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model.
Topics: Animals; Antifibrinolytic Agents; Blood Platelets; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostasis; Liposomes; Liver Diseases; Molecular Mimicry; Nanoparticles; Peptides; Rats, Sprague-Dawley; Tranexamic Acid; Wounds and Injuries | 2019 |
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair.
Topics: Animals; Bile Ducts; Blotting, Western; Fibrinogen; Gene Expression Regulation, Enzymologic; Hepatectomy; Immunohistochemistry; Ligation; Liver; Liver Diseases; Matrix Metalloproteinase 10; Mice; Mice, Knockout; Polymerase Chain Reaction; Regeneration; Toll-Like Receptor 4 | 2014 |
Coagulation management with factor concentrates in liver transplantation: a single-center experience.
Topics: Adult; Algorithms; Blood Coagulation; Blood Coagulation Factors; Blood Component Transfusion; Female; Fibrinogen; Humans; Ischemia; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Thrombelastography; Thrombosis; Transfusion Reaction; Ultrasonography, Doppler | 2014 |
Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.
Topics: Disease Progression; Female; Fibrinogen; Hep G2 Cells; Hepacivirus; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Transplantation; Male; Middle Aged; Peptide Fragments | 2014 |
Hypofibrinogenemia and liver disease: a new case of Aguadilla fibrinogen and review of the literature.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Child; Child, Preschool; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Models, Molecular; Mutation; Pedigree; Protein Conformation; Young Adult | 2015 |
Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
Topics: Afibrinogenemia; Amino Acid Sequence; Child, Preschool; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Predisposition to Disease; Heterozygote; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Models, Molecular; Molecular Sequence Data; Mutation, Missense; Phenotype; Protein Conformation; Structure-Activity Relationship | 2015 |
How to report results of prothrombin and activated partial thromboplastin times.
Topics: Fibrinogen; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Liver Diseases; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Thromboembolism | 2016 |
The fibrous form of intracellular inclusion bodies in recombinant variant fibrinogen-producing cells is specific to the hepatic fibrinogen storage disease-inducible variant fibrinogen.
Topics: Amino Acid Substitution; Animals; CHO Cells; Cricetinae; Cricetulus; Fibrinogen; Hepatocytes; Humans; Inclusion Bodies; Liver Diseases; Mutation, Missense; Recombinant Proteins | 2017 |
The rheological profile of chronic liver disease patients in Nigeria.
Topics: Adult; Aged; Chronic Disease; Female; Fibrinogen; Hematocrit; Hemorheology; Hepatitis C; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Middle Aged; Nigeria; Platelet Count; Prospective Studies; Risk Factors; Young Adult | 2009 |
Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.
Topics: Afibrinogenemia; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Coagulation; Child, Preschool; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; DNA Mutational Analysis; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Genetic Predisposition to Disease; Humans; Inclusion Bodies; International Normalized Ratio; Liver; Liver Diseases; Male; Metabolism, Inborn Errors; Models, Molecular; Mutation; Phenotype; Protein Conformation; Structure-Activity Relationship | 2010 |
Fibrinogenopenia associated with multiple vitamin deficiencies and liver damage.
Topics: Afibrinogenemia; Avitaminosis; Blood; Deficiency Diseases; Fibrinogen; Humans; Liver Diseases | 1946 |
Unexpected laboratory diagnosis: Acquired dysfibrinogenemia in a bleeding patient with liver disease.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Liver Diseases; Middle Aged | 2010 |
[Hemostatic effectiveness of TachoSil® patches in radiofrequency assisted minor hepatic resection].
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Combined Modality Therapy; Drug Combinations; Female; Fibrinogen; Hemostatic Techniques; Hepatectomy; Humans; Liver Diseases; Male; Middle Aged; Surgical Sponges; Thrombin | 2010 |
Coagulation abnormalities in patients with chronic liver disease in Pakistan.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Chronic Disease; Confidence Intervals; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Hospitals, University; Humans; Liver Diseases; Male; Middle Aged; Pakistan; Partial Thromboplastin Time; Prothrombin Time; Risk; Risk Factors; Sex Distribution; Thrombocytopenia; Young Adult | 2011 |
Risk factors and outcomes of massive red blood cell transfusion following living donor liver transplantation.
Topics: Abdomen; Adult; Blood Loss, Surgical; Blood Volume; Chi-Square Distribution; Critical Care; Erythrocyte Transfusion; Fibrinogen; Hemoglobins; Humans; Kaplan-Meier Estimate; Length of Stay; Liver Diseases; Liver Transplantation; Logistic Models; Multivariate Analysis; Platelet Count; Retrospective Studies; Risk Factors; Surgical Wound Infection | 2012 |
Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Feasibility Studies; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Liposomes; Liver Diseases; Male; Microscopy, Immunoelectron; Oligopeptides; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia; Time Factors; Wounds, Penetrating | 2012 |
Factors associated with prophylactic plasma transfusion before vascular catheterization in non-bleeding critically ill adults with prolonged prothrombin time: a case-control study.
Topics: Aged; Bilirubin; Blood Component Transfusion; Case-Control Studies; Catheterization, Central Venous; Catheterization, Peripheral; Cohort Studies; Critical Care; Critical Illness; Erythrocyte Transfusion; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Plasma; Platelet Count; Prospective Studies; Prothrombin Time; United Kingdom | 2012 |
Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis.
Topics: Alleles; Case-Control Studies; Cohort Studies; Female; Fibrinogen; Fibrinogens, Abnormal; Genotype; Haplotypes; Humans; Liver Diseases; Male; Polymorphism, Single Nucleotide; Portal Vein; Venous Thrombosis | 2013 |
Measurement of thrombus precursor protein in septic patients with disseminated intravascular coagulation and liver disease.
Topics: Adult; Aged; Antithrombins; Female; Fibrin; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Platelet Count; Sepsis | 2002 |
Fibrinogen storage disease without hypofibrinogenaemia associated with acute infection.
Topics: Acute Disease; Afibrinogenemia; Aged; Bronchopneumonia; Communicable Diseases; Diarrhea; Female; Fibrinogen; Hepatocytes; Humans; Liver Diseases | 2003 |
Hypercoagulability and liver dysfunction induced by compounds of some heavy metals.
Topics: Antimony; Arsenicals; Bismuth; Coagulants; Diuretics; Fibrinogen; Humans; Liver Diseases; Metals, Heavy; Organomercury Compounds; Prothrombin Time; Thrombophilia | 1954 |
[Fibrinogen and blood protein fractions in acute and chronic liver diseases].
Topics: Blood Proteins; Coagulants; Fibrinogen; Hemostatics; Humans; Liver Diseases | 1957 |
[Differential blood sedimentation (DBS) with determination of the hematocrit volume without centrifugation of the serum gel-forming substances and of fibrinogen in liver diseases].
Topics: Blood Sedimentation; Blood Volume; Centrifugation; Coagulants; Fibrinogen; Hematocrit; Humans; Liver Diseases | 1959 |
[Behavior of fibrinogen and of some other factors participating in blood coagulation during the course of the serial blood coagulation test (Grott's test) in cases of parenchymal liver diseases].
Topics: Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Humans; Liver Diseases | 1962 |
[LIVER AND BLOOD COAGULATION. I. BEHAVIOR OF FACTOR XII (HAGEMAN), OF FACTOR X (STUART) AND OF FIBRINOGEN IN LIVER PATIENTS].
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Factor X; Factor XII; Fibrinogen; Humans; Liver Diseases; Pathology | 1964 |
[BLOOD CLOTTING FACTOR IN HEMOLYSATES].
Topics: Anemia; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Calcium; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; Hemolysis; Humans; Kidney Diseases; Liver Diseases; Prothrombin; Thromboplastin | 1963 |
COAGULATION STUDIES IN LIVER DISEASE.
Topics: Blood Coagulation; Blood Coagulation Factors; Enzyme Inhibitors; Factor IX; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Jaundice; Jaundice, Obstructive; Liver Cirrhosis; Liver Diseases; Prothrombin | 1964 |
[STUDIES ON THE THROMBIN TEST IN LIVER AND BILIARY TRACT DISEASES].
Topics: Biliary Tract Diseases; Blood Coagulation Disorders; Blood Coagulation Tests; Diabetes Mellitus; Fibrinogen; Humans; Liver Diseases; Nephritis; Prothrombin Time; Thrombin | 1964 |
Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Cross-Linking Reagents; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluorometry; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged | 2004 |
Electrophoretic studies in liver disease. I. Comparison of serum and plasma electrophoretic patterns in liver disease, with special reference to fibrinogen and gamma globulin patterns.
Topics: Blood Proteins; Extracellular Space; Fibrinogen; gamma-Globulins; Liver Diseases; Plasma | 1951 |
Liver histology of an afibrinogenemic patient with the Bbeta-L353R mutation showing no evidence of hepatic endoplasmic reticulum storage disease (ERSD); comparative study in COS-1 cells of the intracellular processing of the Bbeta-L353R fibrinogen vs. the
Topics: Adolescent; Animals; Arginine; COS Cells; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Fibrinogen; Genotype; Glycoside Hydrolases; Humans; Immunohistochemistry; Immunoprecipitation; Leucine; Liver; Liver Diseases; Male; Metabolism, Inborn Errors; Microscopy, Electron; Mutation; Mutation, Missense; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Transfection | 2005 |
Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease.
Topics: Afibrinogenemia; Amino Acid Substitution; Autophagy; Endoplasmic Reticulum; Fibrinogen; Golgi Apparatus; Humans; Liver Diseases; Mutation; Pichia; Protein Folding; Protein Transport; Recombinant Proteins; Saccharomyces cerevisiae | 2006 |
Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.
Topics: Adipose Tissue; Animals; Blood Glucose; Chromatography, Thin Layer; Diet; Dietary Fats; Energy Metabolism; Fibrinogen; Genotype; Glucose; Glucose Clamp Technique; Insulin Resistance; Interleukin-10; Lipid Metabolism; Lipids; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Serum Amyloid A Protein | 2006 |
Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation.
Topics: Adult; Area Under Curve; C-Reactive Protein; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Infections; Liver Diseases; Male; Middle Aged; Neoplasms; Pregnancy; Pregnancy Complications; Prognosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Analysis; Wounds and Injuries | 2007 |
A protein chip approach for high-throughput antigen identification and characterization.
Topics: Adult; Animals; Antibodies, Monoclonal; Antigens; Basigin; Biomarkers; Carrier Proteins; Dioxygenases; Eukaryotic Initiation Factor-1; Female; Fibrinogen; Humans; Immunohistochemistry; Liver; Liver Diseases; Liver Neoplasms; Membrane Proteins; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Nuclear Proteins; Protein Array Analysis; Proteins; Reproducibility of Results; Vaccination | 2007 |
Fibrinogen angers with a new deletion (gamma GVYYQ 346-350) causes hypofibrinogenemia with hepatic storage.
Topics: Adult; Base Sequence; Endoplasmic Reticulum, Rough; Family Health; Female; Fibrinogen; Fluorescent Antibody Technique, Indirect; Gene Deletion; Hepatitis C; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Protective role of metallothionein in coagulatory disturbance accompanied by acute liver injury induced by LPS/D-GalN.
Topics: Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Galactosamine; Lipopolysaccharides; Liver; Liver Diseases; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Count; Time Factors | 2008 |
Coagulation properties of human thoracic duct lymph.
Topics: Blood Coagulation Factors; Erythrocyte Count; Factor V; Factor VII; Factor X; Fibrinogen; Fibrinolysis; Gastrointestinal Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Neoplasms; Lymph; Prothrombin; Prothrombin Time; Thoracic Duct; Thromboplastin | 1967 |
Multiple coagulation defects in association with dissecting aneurysm.
Topics: Aortic Aneurysm; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Liver Diseases; Middle Aged; Necrosis; Prothrombin | 1967 |
A clinical evaluation of serum alpha-1-antichymotrypsin levels in liver disease and cancers.
Topics: alpha 1-Antichymotrypsin; alpha-Fetoproteins; Blood Sedimentation; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Chymotrypsin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Sialic Acids | 1981 |
[Micromethod for the quantitative determination of fibrinogen].
Topics: Chemical Precipitation; Fibrinogen; Humans; Liver Diseases; Microchemistry | 1982 |
Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease.
Topics: Afibrinogenemia; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Sialic Acids; Thrombin Time | 1982 |
Plasma fibronectin levels in clinical disease states and after cryoprecipitate infusion.
Topics: Adult; Aged; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Fibronectins; Hemophilia A; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged | 1984 |
The abnormal carbohydrate composition of the dysfibrinogenemia associated with liver disease.
Topics: Afibrinogenemia; Carbohydrates; Fibrin; Fibrinogen; Humans; Liver Diseases; Sialic Acids; Thrombin Time | 1983 |
Observations on the heterogeneity of fibronectin C.
Topics: Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibronectins; Humans; Immunoelectrophoresis, Two-Dimensional; Liver Diseases | 1984 |
Hepatitis B surface antigen (HBsAg)-fibrinogen interaction.
Topics: Antigen-Antibody Reactions; Fibrinogen; Hepatitis B; Hepatitis B Surface Antigens; Humans; Liver; Liver Diseases | 1984 |
The role of sodium citrate in the dysfibrinogenaemia of liver disease.
Topics: Afibrinogenemia; Blood Coagulation; Citrates; Citric Acid; Diagnosis, Differential; Fibrinogen; Humans; Liver Diseases; Sialic Acids; Thrombin Time | 1984 |
[Differential diagnostic importance of the immunochemical determination of blood serum, bile and urinary proteins in chronic liver and biliary tract diseases].
Topics: Albumins; Bile; Biliary Tract Diseases; Blood Proteins; Chronic Disease; Diagnosis, Differential; Fibrinogen; Humans; Immunodiffusion; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Liver Diseases; Proteinuria | 1980 |
The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains.
Topics: Afibrinogenemia; Borohydrides; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Liver Diseases; Neuraminidase; Sialic Acids; Thrombin Time | 1983 |
Hemostasis testing during massive blood replacement. A study of 172 cases.
Topics: Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Extracorporeal Circulation; Fibrinogen; Freezing; Hemostatic Techniques; Humans; Liver Diseases; Partial Thromboplastin Time; Plasma; Platelet Count; Platelet Transfusion; Prothrombin Time; Thrombin Time; Transfusion Reaction | 1982 |
Acquired dysfibrinogenaemia in liver disease.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Cholestasis; Diagnosis, Differential; Fibrinogen; Humans; Jaundice; Liver Diseases | 1982 |
A naturally occurring antibody that inhibits fibrin polymerization.
Topics: Adolescent; Autoantibodies; Blood Coagulation Disorders; Blood Coagulation Tests; Colitis, Ulcerative; Female; Fibrin; Fibrinogen; Humans; Immunoglobulin G; Liver Diseases; Polymers | 1981 |
Intraperitoneal coagulation in chronic liver disease ascites.
Topics: Ascites; Ascitic Fluid; Blood Coagulation; Blood Proteins; Chronic Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Diseases; Peritoneal Cavity | 1981 |
Human factor XIII: fibrin-stabilizing factor.
Topics: Blood Coagulation; Blood Coagulation Disorders; Blood Transfusion; Calcium; Disseminated Intravascular Coagulation; Factor XIII; Factor XIII Deficiency; Female; Fibrin; Fibrinogen; Half-Life; Hemorrhage; Humans; Leukemia; Liver Diseases; Male; Plasma; Pregnancy; Thrombin; Time Factors | 1980 |
[Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate].
Topics: Alkaline Phosphatase; Ammonia; Bilirubin; Caproates; Chronic Disease; Copper; Disulfides; Female; Fibrinogen; Humans; Hyperbilirubinemia; Iron; L-Lactate Dehydrogenase; Liver Diseases; Male; Transaminases | 1980 |
Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen.
Topics: Afibrinogenemia; Aged; Ascites; Ascitic Fluid; Blood Proteins; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Peritoneovenous Shunt; Plasminogen | 1980 |
Role of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice.
Topics: Acute-Phase Proteins; Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Fibrinogen; Galactosamine; Homeostasis; Immunity, Innate; Interleukin-1; Interleukin-6; Klebsiella Infections; Klebsiella pneumoniae; Liver Diseases; Mice; Pseudomonas Infections | 1993 |
Comparison of the kinetic fibrinogen assay with the von Clauss method and the clot recovery method in plasma of patients with conditions affecting fibrinogen coagulability.
Topics: Anticoagulants; Blood Coagulation Disorders; Evaluation Studies as Topic; Fibrinogen; Hematology; Heparin; Humans; Kinetics; Liver Diseases; Osmolar Concentration; Warfarin | 1995 |
Quantification of thrombelastographic changes after blood component transfusion in patients with liver disease in the intensive care unit.
Topics: Blood Coagulation Disorders; Blood Component Transfusion; Blood Viscosity; Critical Care; Factor VIII; Fibrinogen; Fibronectins; Hemostasis, Surgical; Humans; Liver Diseases; Liver Transplantation; Monitoring, Physiologic; Plasma; Platelet Transfusion; Thrombelastography; Thrombin Time | 1995 |
Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury.
Topics: Animals; Blotting, Northern; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Female; Fibrin; Fibrinogen; Gene Expression; Immunohistochemistry; In Situ Hybridization; Liver; Liver Cirrhosis, Experimental; Liver Diseases; Necrosis; Rats; Rats, Wistar; RNA, Messenger | 1995 |
Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response.
Topics: Acute-Phase Proteins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bacteremia; Biological Assay; Blotting, Northern; Carrier Proteins; Disease Models, Animal; Endotoxins; Evaluation Studies as Topic; Fibrinogen; Inflammation; Interleukin-6; Liver Diseases; Macrophages; Male; Membrane Glycoproteins; Peritoneum; Rats; Rats, Sprague-Dawley; RNA Probes; Tumor Necrosis Factor-alpha | 1993 |
Haemostatic and immunological sequelae of portacaval shunt in rats.
Topics: Animals; Cell Division; Chronic Disease; Cytokines; Fibrinogen; Hemostasis; Kupffer Cells; Liver Diseases; Lymphocytes; Male; Portacaval Shunt, Surgical; Postoperative Complications; Rats | 1995 |
Peroxisome proliferation associated with fibrinogen storage in the liver.
Topics: Child; Female; Fibrinogen; Humans; Liver; Liver Diseases; Metabolism, Inborn Errors; Microbodies | 1996 |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
Topics: Administration, Oral; Alanine Transaminase; Animals; Azepines; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Hydroxyurea; Injections, Intraperitoneal; Injections, Intravenous; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Diseases; Necrosis; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombocytopenia; Triazoles | 1997 |
Disseminated intravascular coagulation in chickens inoculated with Erysipelothrix rhusiopathiae.
Topics: Animals; Blood Coagulation; Chickens; Disseminated Intravascular Coagulation; Erysipelothrix; Erysipelothrix Infections; Fibrinogen; Injections, Intramuscular; Kidney Diseases; Liver Diseases; Lung Diseases; Partial Thromboplastin Time; Prothrombin Time; Thrombosis | 1997 |
Acquired dysfibrinogenemia following allogeneic bone marrow transplantation.
Topics: Adult; Afibrinogenemia; Blood Coagulation; Bone Marrow Transplantation; Female; Fibrinogen; Humans; Liver Diseases; Liver Function Tests; Transplantation, Homologous | 1997 |
[Application of wound coat "Tachocomb" in surgical interventions on liver and pancreas].
Topics: Adolescent; Adult; Aprotinin; Blood Loss, Surgical; Drug Combinations; Female; Fibrinogen; Hemostasis, Surgical; Hepatectomy; Humans; Liver Diseases; Male; Middle Aged; Pancreatectomy; Pancreatic Diseases; Postoperative Complications; Retrospective Studies; Thrombin; Wound Healing | 1998 |
Massive liver haemorrhage and rupture caused by HELLP-syndrome treated by collagen fleeces coated with fibrin glue.
Topics: Adult; Aprotinin; Drug Combinations; Female; Fibrinogen; HELLP Syndrome; Hemorrhage; Hemostasis, Surgical; Humans; Liver Diseases; Pregnancy; Rupture, Spontaneous; Thrombin | 1998 |
Prothrombin time derived fibrinogen determination on Sysmex CA-6000.
Topics: Animals; Anticoagulants; Critical Illness; Fibrinogen; Hemoglobinopathies; Humans; Kidney Diseases; Liver Diseases; Prothrombin Time; Rabbits; Reference Values; Statistics, Nonparametric | 1998 |
Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.
Topics: Acute Disease; Adsorption; Bilirubin; Biocompatible Materials; Chronic Disease; Dialysis; Equipment Design; Equipment Safety; Fibrinogen; Filtration; Hemodiafiltration; Humans; Immunoglobulin G; Immunoglobulin M; Liver Diseases; Membranes, Artificial; Molecular Weight; Polymers; Protein Binding; Serum Albumin; Sulfones; Tryptophan | 1999 |
Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family.
Topics: Amyloidosis; England; Female; Fibrinogen; Follow-Up Studies; Humans; Kidney Diseases; Kidney Transplantation; Liver; Liver Diseases; Liver Transplantation; Middle Aged; Mutation; Peptide Fragments; Polymorphism, Restriction Fragment Length; Radionuclide Imaging; Spleen | 2000 |
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs.
Topics: Adenoviridae; Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gene Expression; Gene Transfer Techniques; Genetic Vectors; Hemophilia A; Isoantibodies; Liver Diseases; Male; Models, Animal; Phenotype; Platelet Count; Time Factors | 2001 |
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver disease.
Topics: Fibrinogen; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Diseases | 2001 |
Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Diagnostic Errors; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Liver Diseases; Male; Middle Aged; Renal Dialysis; Serum Globulins; Time Factors | 2001 |
Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation Tests; Coagulation Protein Disorders; Female; Fibrinogen; Humans; Immunoenzyme Techniques; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Predictive Value of Tests; Reproducibility of Results | 2002 |
Use of factor-VII-rich prothrombin complex concentrate in liver disease.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Factor V; Factor VII; Fibrinogen; Humans; Infusions, Parenteral; Liver Diseases; Phosphatidylethanolamines; Prothrombin; Thrombin; Time Factors | 1975 |
[Localization of HBsAg, immunoglobulins, fibrin and C3 in the liver by direct immunoflourescence].
Topics: Biopsy; Complement C3; Complement System Proteins; Cytoplasm; Epitopes; Fatty Liver; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Hepatitis; Hepatitis B Antigens; Humans; Immunoglobulins; Liver; Liver Cirrhosis; Liver Diseases; Renal Dialysis | 1976 |
Abnormal fibrin polymerization in liver disease.
Topics: Batroxobin; Blood Coagulation Tests; Carcinoma, Hepatocellular; Cholestasis; Chronic Disease; Fibrin; Fibrinogen; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polymers; Thrombin; Time Factors | 1976 |
Coagulation abnormalities in liver disease.
Topics: Acute Disease; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Carcinoma, Hepatocellular; Chronic Disease; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XIII; Fibrinogen; Hepatitis; Humans; Jaundice, Chronic Idiopathic; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Neoplasm Metastasis; Prothrombin; Vitamin K | 1977 |
Simple, sensitive method for measuring plasmin and plasminogen activity in plasma.
Topics: Enzyme Activation; Female; Fibrinogen; Fibrinolysin; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Diseases; Male; Neoplasms; Plasminogen; Pregnancy; Pregnancy Trimester, First; Spectrophotometry; Streptokinase; Thrombosis | 1975 |
Investigations on intravascular coagulation in liver disease: souble fibrin monomer complexes in liver cirrhosis.
Topics: Bacteriological Techniques; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Liver Cirrhosis; Liver Diseases; Solubility; Staphylococcus | 1979 |
Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver disease.
Topics: Adult; Aged; Blood Protein Electrophoresis; Electrophoresis, Polyacrylamide Gel; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Diseases; Male; Middle Aged; Molecular Weight; Plasminogen Activators; Plasminogen Inactivators | 1977 |
Association of abnormal fibrin polymerisation with severe liver disease.
Topics: Aspartate Aminotransferases; Bilirubin; Blood Coagulation Disorders; Chronic Disease; Factor VII; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Serum Albumin; Serum Globulins | 1977 |
Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.
Topics: Blood Coagulation Disorders; Chemical Phenomena; Chemistry; Fibrinogen; Humans; Liver Diseases; Sialic Acids | 1978 |
Dysfibrinogenaemia and liver cell growth.
Topics: Batroxobin; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Humans; Liver Diseases; Liver Neoplasms; Liver Regeneration | 1978 |
[Clinical significance of fibrinogen heterogeneity].
Topics: Blood Coagulation Disorders; Chemical Phenomena; Chemistry; Fibrinogen; Humans; Liver Diseases; Molecular Weight | 1978 |
Fetal fibrinogen: fact or fancy?
Topics: Adult; Animals; Female; Fetal Blood; Fibrinogen; Humans; Liver; Liver Diseases; Pregnancy | 1978 |
[Blood coagulation disorders in acute liver failure and substitution therapy (proceedings)].
Topics: Blood Coagulation Disorders; Blood Transfusion; Fibrinogen; Heparin; Humans; Liver Diseases; Liver Transplantation | 1976 |
[S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].
Topics: Adult; Aged; Blood Sedimentation; Blood Viscosity; Chronic Disease; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; S-Adenosylmethionine; Thrombelastography | 1977 |
Acquired dysfibrinogenaemia in acute and chronic liver disease.
Topics: Acute Disease; Ancrod; Batroxobin; Blood Coagulation Disorders; Blood Coagulation Tests; Chronic Disease; Fibrin; Fibrinogen; Humans; Liver Diseases; Thrombin | 1977 |
Dysfibrinogenemia associated with liver disease.
Topics: Alcoholism; Batroxobin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Chemical and Drug Induced Liver Injury; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Thrombin | 1977 |
Prolonged thrombin clotting times in liver disease.
Topics: Blood Coagulation Tests; Fibrinogen; Humans; Liver Diseases; Thrombin | 1977 |
[Fibrinogen concentration and its ratio to other protein fractions in chronic alcoholism].
Topics: Adolescent; Adult; Aged; Chronic Disease; Fibrinogen; Humans; Liver Diseases; Middle Aged; Serum Albumin; Serum Globulins | 1976 |
Hypofibrinogenemia associated with vincristine and prednisone therapy in lymphoblastic leukemia.
Topics: Adult; Afibrinogenemia; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Iodine Radioisotopes; Leukemia; Leukemia, Lymphoid; Liver Diseases; Male; Prednisone; Prospective Studies; Time Factors; Vincristine | 1975 |
[Changes of hemostasis in liver diseases. I. Value of biological tests in the diagnosis of those diseases].
Topics: Diagnosis, Differential; Fibrinogen; Hemostasis; Humans; Liver Diseases; Liver Neoplasms; Prothrombin Time; Thrombelastography | 1975 |
[Changes of blood-flow properties in patients with chronic liver disease (author's transl)].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Viscosity; Chronic Disease; Cortisone; Esophageal and Gastric Varices; Fibrinogen; Hepatitis; Humans; Hypertension, Portal; Immunoglobulin G; Immunosuppression Therapy; Liver Cirrhosis; Liver Diseases; Middle Aged | 1975 |
Letter: Fibrinogen in liver disease.
Topics: Endotoxins; Fibrinogen; Humans; Liver Diseases; Platelet Aggregation | 1975 |
Endotoxin-induced liver necrosis and intravascular coagulation in rats enhanced by portacaval collateral circulation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Blood Coagulation Factors; Blood Glucose; Blood Volume; Cardiac Output; Collateral Circulation; Endotoxins; Erythrocyte Aggregation; Fibrin; Fibrinogen; Hypertension, Portal; Liver; Liver Circulation; Liver Diseases; Necrosis; Phagocytosis; Portacaval Shunt, Surgical; Rats; Regional Blood Flow; Time Factors | 1975 |
Prothrombin complex and fibrinogen.
Topics: Blood Transfusion; Dextrans; Factor IX; Fibrinogen; Fractional Precipitation; Hemophilia B; Hepatitis B; Humans; Ion Exchange; Liver Diseases; Prothrombin; Ultraviolet Rays | 1975 |
Thromboembolic complications.
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Liver Diseases; Plasminogen; Postoperative Complications; Prothrombin; Thromboembolism | 1975 |
[Current sero-diagnosis of liver diseases. II].
Topics: Fibrinogen; Humans; Liver Diseases; Prothrombin Time; Serologic Tests | 1975 |
Coagulation studies as a prognostic index in acute liver failure.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Child; Factor V; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged; Phosphatidylethanolamines; Prognosis; Prothrombin; Serum Globulins; Time Factors | 1975 |
Proceedings: Abnormal fibrin monomer polymerization in liver disease.
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Diseases | 1975 |
[Abnormal fibrinogens in liver disorders].
Topics: Blood Coagulation Tests; Female; Fibrinogen; Humans; Liver Diseases; Male; Middle Aged | 1976 |
Physiological inhibitors of coagulation in fulminant hepatic failure.
Topics: Antithrombin III; Blood Coagulation; Fibrinogen; Heparin Cofactor II; Humans; Liver Diseases; Peptide Fragments; Protein C; Ribonuclease, Pancreatic | 1992 |
Fibrinolysis and fibrinogenolysis in liver disease.
Topics: Antithrombin III; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Liver Diseases; Peptide Hydrolases; Plasminogen Inactivators | 1990 |
[Acquired dysfibrinogenemia in a child in the course of a liver disease].
Topics: Adolescent; Afibrinogenemia; Autoimmune Diseases; Blood Coagulation Tests; Fibrinogen; Humans; Liver Diseases; Male; Prednisolone; Thrombin Time | 1990 |
Spontaneous intracerebral hemorrhage and liver dysfunction.
Topics: Adult; Aged; Alanine Transaminase; Alcohol Drinking; Aspartate Aminotransferases; Cerebral Hemorrhage; Female; Fibrinogen; gamma-Globulins; Humans; Hypertension; Liver Diseases; Male; Middle Aged; Sex Factors; Thrombocytopenia | 1988 |
Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation.
Topics: Animals; Antithrombin III; Collodion; Disseminated Intravascular Coagulation; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Glycoproteins; Humans; Immunoassay; Liver Diseases; Mice; Molecular Weight; Polymorphism, Genetic; Vitronectin | 1988 |
Indices of growth and death of liver cells in human chronic liver disease.
Topics: alpha-Fetoproteins; Aspartate Aminotransferases; Chronic Disease; Fibrinogen; gamma-Glutamyltransferase; Humans; Liver; Liver Diseases; Liver Regeneration; Ornithine Carbamoyltransferase; Thrombin Time | 1987 |
Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Topics: Adolescent; alpha-2-Antiplasmin; Aminocaproic Acid; Blood Coagulation Disorders; Child; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Liver Diseases; Male; Neoplasm Metastasis | 1989 |
Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions.
Topics: Adult; Carcinoma, Hepatocellular; Complement C3; Complement C4; Endoplasmic Reticulum; Fibrinogen; Hepatitis B; Humans; Hyalin; Inclusion Bodies; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male | 1989 |
Analysis of elevated fibrin(ogen) degradation product levels in patients with liver disease.
Topics: Agglutination; Alcoholism; Antibodies; Electrophoresis, Polyacrylamide Gel; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemosiderosis; Hepatitis; Humans; Immunosorbent Techniques; Liver Cirrhosis; Liver Diseases; Molecular Weight; Platelet Count; Polymers; Thrombin Time | 1986 |
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
Topics: Alanine Transaminase; Animals; Blood Coagulation Disorders; Enzyme Activation; Escherichia coli; Factor V; Factor VIII; Fibrinogen; Leukocyte Count; Liver Diseases; Papio; Protein C; Shock, Septic | 1987 |
Relationship of fibrinogen-bound sialic acid and liver disease in patients with lymphoma.
Topics: Female; Fibrinogen; Hodgkin Disease; Humans; Liver Diseases; Lymphoma, Non-Hodgkin; Male; Protein Binding; Sialic Acids | 1988 |
Transplantation of cryopreserved hepatocytes or liver cytosol injection in the treatment of acute liver failure in rats.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Bilirubin; Cell Separation; Cell Survival; Cytosol; Fibrinogen; Freezing; Galactosamine; Injections, Intraperitoneal; Liver Diseases; Liver Transplantation; Male; Partial Thromboplastin Time; Rats; Rats, Inbred Lew; Tissue Preservation | 1986 |
Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: investigation of A alpha-chain N-terminal heterogeneity.
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Female; Fetal Blood; Fibrinogen; Fibrinopeptide A; Humans; Infant, Newborn; Kinetics; Liver Diseases; Macromolecular Substances; Pregnancy; Rectal Neoplasms; Reference Values; Thrombin | 1986 |
A reproducible model of acute hepatic failure by transient ischemia in the pig.
Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Electroencephalography; Electrophysiology; Fibrinogen; Guinea Pigs; Hemodynamics; Ischemia; Liver; Liver Diseases; Necrosis; Platelet Count; Portacaval Shunt, Surgical | 1987 |
Chronic liver disease animal model for evaluation of artificial liver support systems.
Topics: Animals; Body Weight; Chronic Disease; Disease Models, Animal; Dogs; Fibrinogen; Galactosamine; Hepatitis, Chronic; Liver Diseases; Male; Necrosis; Partial Thromboplastin Time; Prothrombin Time | 1985 |
Influence of antithrombin III on carbon tetrachloride intoxication of rabbits.
Topics: Alanine Transaminase; Animals; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Heparin; Liver Diseases; Male; Rabbits; Thrombin | 1985 |
Effects of preeclampsia on maternal and cord blood clotting activity.
Topics: Apgar Score; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fetal Blood; Fibrinogen; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Liver Diseases; Partial Thromboplastin Time; Pre-Eclampsia; Pregnancy; Prothrombin Time; Vitamin K Deficiency | 1985 |
[Hemostatic studies on acquired abnormal fibrinogenemia in severe liver diseases and umbilical cord blood].
Topics: Fetal Blood; Fibrinogen; Humans; Liver Diseases; N-Acetylneuraminic Acid; Sialic Acids | 1985 |
[Clinical value of determining fibrinogen level in liver diseases].
Topics: Diagnosis, Differential; Fibrinogen; Humans; Liver Diseases; Reference Standards | 1985 |
Immunopathological studies of orthotopic human liver allografts.
Topics: Adolescent; Adult; Autopsy; Azathioprine; Biliary Tract Diseases; Biopsy; Child; Child, Preschool; Complement System Proteins; Female; Fibrinogen; Fluorescent Antibody Technique; Graft Rejection; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulins; Infant; Liver; Liver Diseases; Liver Transplantation; Male; Microscopy, Electron; Middle Aged; Prednisone; Time Factors; Transplantation Immunology; Transplantation, Homologous | 1972 |
[New plasma derivatives].
Topics: Anemia, Neonatal; Blood Coagulation Factors; Dicumarol; Erythroblastosis, Fetal; Factor VIII; Female; Fibrinogen; Hemophilia A; Hemophilia B; Hemorrhage; Hepatitis A; Humans; Immunization, Passive; Immunoglobulins; Infant, Newborn; Infusions, Parenteral; Injections, Intravenous; Liver Diseases; Plasma; Pregnancy; Tetanus; Tissue Extracts | 1972 |
[Fibrinolytic potential of the blood in liver damage].
Topics: Antithrombins; Blood Coagulation Tests; Caseins; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Mushroom Poisoning; Plasminogen; Prothrombin Time; Thromboplastin | 1974 |
Changes in the rates of synthesis of certain plasma proteins following tissue damage due to talc injection. A study using the perfused rat liver.
Topics: Adrenal Glands; Alpha-Globulins; Animals; Blood; Blood Proteins; Carbon Isotopes; Chemical and Drug Induced Liver Injury; Chemical Precipitation; Chromatography; Electrophoresis; Fibrinogen; Immune Sera; Leucine; Liver; Liver Diseases; Mucoproteins; Perfusion; Rats; Talc; Time Factors | 1968 |
[Methods for the quantitative determination of plasma proteins by immunoprecipitation].
Topics: Arthritis; Ataxia Telangiectasia; Blood Protein Disorders; Blood Proteins; Ceruloplasmin; Chemical Precipitation; Fibrinogen; gamma-Globulins; Humans; Immunochemistry; Immunodiffusion; Immunologic Deficiency Syndromes; Inflammation; Kidney Diseases; Lipoproteins; Liver Diseases; Macroglobulins; Methods; Serum Albumin; Transferrin; Trypsin Inhibitors | 1968 |
Indications and clinical effect of fibrinogen preparations.
Topics: Afibrinogenemia; Blood Platelets; Blood Transfusion; Fibrinogen; gamma-Globulins; Gastrointestinal Hemorrhage; Hepatitis; Humans; Liver Diseases; Thrombocytopenia | 1969 |
Intravascular coagulation in acute hepatic necrosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fibrinogen; Heparin; Humans; Iodine Isotopes; Liver Diseases; Male; Middle Aged; Necrosis; Prothrombin Time | 1970 |
Intravascular coagulation in acute hepatic necrosis.
Topics: Blood Coagulation Disorders; Factor VIII; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Liver Diseases; Necrosis | 1970 |
[Therapy with fibrinogen].
Topics: Afibrinogenemia; Aminocaproates; Blood Coagulation Tests; Cyclohexanecarboxylic Acids; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Liver Diseases | 1968 |
Plasma fibrinogen in health and disease. Its application in the differential diagnosis of an enlarged and irregular liver.
Topics: Adult; Aged; Alcoholism; Carcinoma, Hepatocellular; Fatty Liver; Fibrinogen; Hepatomegaly; Humans; Intestinal Neoplasms; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1972 |
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases].
Topics: Adenocarcinoma; Adult; Aged; Alcoholism; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Giant Cell Arteritis; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prognosis | 1973 |
Fibrinogen in liver disease.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Cholangitis; Cholestasis; Contusions; Endotoxins; Fibrinogen; Humans; Iodine Radioisotopes; Liver; Liver Cirrhosis; Liver Diseases; Pseudomonas Infections; Sepsis; Toxemia | 1974 |
Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
Topics: Acute Disease; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemoglobins; Heparin; Humans; Liver Diseases; Male; Methods | 1973 |
Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications.
Topics: Acetaminophen; Acute Disease; Bilirubin; Biopsy; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Transfusion; Chemical and Drug Induced Liver Injury; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Heparin; Humans; Iodine Radioisotopes; Liver Diseases; Prothrombin Time | 1973 |
The diagnostic value of coagulation studies in chronic liver disease.
Topics: Blood Coagulation Tests; Chronic Disease; Factor V; Fibrinogen; Hepatitis; Humans; Indicators and Reagents; Liver Cirrhosis; Liver Diseases; Methods; Prothrombin Time | 1973 |
Effect of tracer doses of radiopharmaceutic substances labelled with gold ( 198 Au), indium ( 113m In) and Mercury ( 203 Hg) on blood clotting.
Topics: Blood Coagulation; Blood Platelets; Fibrinogen; Gold Colloid, Radioactive; Humans; Indium; Kidney Diseases; Liver Diseases; Mercury Isotopes; Platelet Adhesiveness; Prothrombin; Radiation Effects; Radioisotopes; Radionuclide Imaging; Thromboplastin; Time Factors | 1972 |
Parallel determinations of FDP and fibrin monomers with various methods.
Topics: Animals; Blood Coagulation Tests; Ethanol; Evaluation Studies as Topic; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Neoplasms; Peptide Hydrolases; Postoperative Complications; Postpartum Period; Pregnancy; Protamines; Snakes; Thrombin; Venoms | 1972 |
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms | 1972 |
Jaundice following cardiopulmonary by-pass.
Topics: Age Factors; Alanine Transaminase; Aortic Valve; Aspartate Aminotransferases; Blood Donors; Chemical and Drug Induced Liver Injury; Extracorporeal Circulation; Fibrinogen; Heart Failure; Heart-Lung Machine; Hemolysis; Hepatitis; Hepatitis A; Humans; Hypoxia; Jaundice; Liver Diseases; Mitral Valve; Postoperative Complications; Sulfobromophthalein; Time Factors; Transfusion Reaction | 1973 |
In vivo behavior of fibrinogen fragment D in experimental renal, hepatic and reticuloendothelial dysfunction.
Topics: Animals; Chromatography; Chromatography, Gel; Fibrinogen; Freund's Adjuvant; Hepatectomy; Immune Sera; Immunoelectrophoresis; Iodine Isotopes; Kidney Diseases; Liver Diseases; Mononuclear Phagocyte System; Nephrectomy; Rabbits | 1973 |
Prolonged prothrombin time and partial thromboplastin time in disseminated intravascular coagulation not due to deficiency of factors V and VIII.
Topics: Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Factor V Deficiency; Factor VIII; Fibrinogen; Heparin; Humans; Liver Diseases; Prothrombin Time; Thromboplastin; Vitamin K; Vitamin K Deficiency | 1973 |
Experimental hepatic necrosis: studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen.
Topics: Animals; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Tests; Body Weight; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclohexanecarboxylic Acids; Female; Fibrinogen; Hematocrit; Heparin; Iodine Isotopes; Liver; Liver Diseases; Necrosis; Organ Size; Prothrombin Time; Rats | 1973 |
The value of factor VIII levels in acquired hypofibrinogenemia.
Topics: Adolescent; Adult; Afibrinogenemia; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Child; Child, Preschool; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Female; Fibrinogen; Humans; Infant; Liver; Liver Diseases; Male; Middle Aged; Prothrombin; Prothrombin Time; Serum Globulins; Solubility; Thromboplastin | 1973 |
Disorderd hemostasis in liver damage from paracetamol overdose.
Topics: Acetaminophen; Adult; Bilirubin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Hepatic Encephalopathy; Humans; Iodine Radioisotopes; Liver Diseases; Liver Function Tests; Male; Middle Aged; Plasminogen; Prothrombin Time | 1973 |
Complement and liver cell function in 53 patients with liver disease.
Topics: Adult; Aged; Child; Cholesterol; Complement System Proteins; Factor V; Factor VII; Factor X; Female; Fibrinogen; Glomerulonephritis; Hepatitis; Humans; Immunologic Deficiency Syndromes; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Prothrombin; Prothrombin Time; Purpura, Thrombocytopenic; Serum Albumin | 1973 |
Value of determination of F.D.P. during pregnancy by immunochemical and latex agglutination inhibition methods.
Topics: Diabetes Mellitus; Evaluation Studies as Topic; Female; Fibrin; Fibrinogen; Glycosuria; Humans; Immunoelectrophoresis; Latex Fixation Tests; Liver Diseases; Methods; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Urinary Tract Infections | 1974 |
Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Child; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Liver; Liver Diseases; Male; Middle Aged; Plasminogen; Prognosis | 1974 |
Coagulopathy in non-cirrhotic portal fibrosis.
Topics: Biopsy; Blood Coagulation Disorders; Blood Coagulation Tests; Child; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension, Portal; Iodine Radioisotopes; Liver Diseases; Liver Function Tests; Portal System; Splenomegaly; Syndrome | 1974 |
Bleeding disorders during surgery.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Humans; Liver Diseases; Male; Neoplasms; Purpura, Thrombocytopenic; Surgical Procedures, Operative; Thrombocytopenia; Transfusion Reaction | 1974 |
Endotoxin and acute renal failure associated with obstructive jaundice.
Topics: Acute Kidney Injury; Animals; Blood Coagulation Tests; Blood Platelets; Cholestasis; Endotoxins; Escherichia coli; Fibrin; Fibrinogen; Kidney Diseases; Liver Diseases; Prothrombin Time; Rats; Thrombelastography; Thrombin | 1970 |
Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool.
Topics: Antigens; Blood; Blood Protein Disorders; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Kidney Diseases; Kidney Transplantation; Leukemia; Liver Diseases; Neoplasms; Pregnancy; Thromboembolism | 1971 |
Separation and estimation split "products" of fibrinogen and fibrin in human serum.
Topics: Aminocaproates; Aprotinin; Cellulose; Chromatography; Chromatography, Gel; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Immunoelectrophoresis; Liver Diseases; Macroglobulins; Neoplasms; Plasminogen; Streptokinase; Thrombin; Thrombosis | 1967 |
Study of the defibrination syndrome associated with acute hepatic failure.
Topics: Aminocaproates; Animals; Antibodies; Blood Coagulation Disorders; Blood Pressure; Bradykinin; Chemical Precipitation; Disseminated Intravascular Coagulation; Dogs; Fibrinogen; Fibrinolysis; Haplorhini; Heparin; Hepatectomy; Immunoelectrophoresis; Liver Diseases; Peptide Hydrolases; Plasminogen; Pulse; Serum Albumin, Radio-Iodinated; Temperature; Time Factors | 1971 |
Clinical experience with determination of fibrinogen degradation products.
Topics: Acute Kidney Injury; Arteritis; Female; Fibrinogen; Hemorrhage; Humans; Immunodiffusion; Kidney Failure, Chronic; Liver Diseases; Methods; Neoplasms; Pneumonia; Pregnancy; Pregnancy Complications; Thromboembolism | 1971 |
Fibrinogen metabolism in healthy dogs and in dogs with CCl 4 -induced liver damage and with portal vein occlusion.
Topics: Animals; Body Weight; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Dogs; Female; Fibrinogen; Half-Life; Heparin; Iodine Isotopes; Ligation; Liver Diseases; Male; Plasma Volume; Portal Vein; Vascular Diseases | 1972 |
Haemorrhage as a complication of extracorporeal pig liver perfusion: studies on mechanism and prevention.
Topics: Adolescent; Adult; Ammonia; Animals; Bile; Bilirubin; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Hemorrhage; Humans; Iodine Radioisotopes; Ischemia; Liver Circulation; Liver Diseases; Male; Perfusion; Sulfobromophthalein; Swine | 1972 |
The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
Topics: Antibodies; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Hyperthyroidism; Kidney Diseases; Latex; Liver Diseases; Methods; Microspheres; Neoplasms; Pulmonary Embolism | 1972 |
A model which can be used to improve the treatment of acute hepatic failure.
Topics: Albumins; Anesthesia, General; Animals; Biotransformation; Blood Coagulation; Blood Pressure; Fibrinogen; Glucose; Halothane; Hepatic Encephalopathy; Iodine Isotopes; Liver; Liver Diseases; Methods; Models, Biological; Parabiosis; Sulfobromophthalein; Swine | 1972 |
125-I fibrinogen studies and intravascular coagulation in the isolated perfused pig liver.
Topics: Animals; Blood Coagulation; Fibrinogen; Humans; In Vitro Techniques; Iodine Isotopes; Liver; Liver Diseases; Perfusion; Swine | 1971 |
[Physiopathology of disseminated intravascular coagulation].
Topics: Blood Coagulation Factors; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Liver Diseases; Platelet Adhesiveness | 1971 |
Intravascular coagulation in acute hepatic necrosis: clinical and experimental studies into the deposition of microthrombi and the effect of treatment.
Topics: Acute Disease; Animals; Biopsy; Blood Transfusion; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Disseminated Intravascular Coagulation; Fibrinogen; Heparin; Hepatic Encephalopathy; Humans; Iodine Isotopes; Liver; Liver Diseases; Microscopy, Electron; Necrosis; Prothrombin Time; Rats | 1971 |
[Diagnostic clarification of coagulopathies].
Topics: Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Fibrinogen; Hemorrhagic Disorders; Hemostasis; Humans; Liver Diseases; Prothrombin Time; Thrombin; Thrombocytopenia; Thromboplastin | 1971 |
Gastrointestinal bleeding in liver disease.
Topics: Aminocaproates; Blood Coagulation Disorders; Blood Transfusion; Duodenal Ulcer; Esophageal and Gastric Varices; Esophagitis; Fibrinogen; Fibrinolysis; Gastritis; Gastrointestinal Hemorrhage; Heparin; Humans; Liver Diseases; Phosphorus Isotopes; Portacaval Shunt, Surgical; Stomach Ulcer; Therapeutic Irrigation; Vasopressins; Vitamin K | 1971 |
Chronic intravascular coagulation (IFC) syndrome.
Topics: Blood Coagulation Disorders; Chromium Isotopes; Chronic Disease; Fibrinogen; Hemangioma; Hemoglobinuria, Paroxysmal; Humans; Iodine Isotopes; Liver Diseases; Neoplasms; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia | 1969 |
Plasma fibrinogen: determination, normal values, physiopathologic shifts, and fluctuations.
Topics: Blood Coagulation; Blood Coagulation Disorders; Chemical Precipitation; Densitometry; Diabetes Mellitus; Fibrinogen; Glycine; Liver Diseases; Methods; Quaternary Ammonium Compounds; Sulfates; Ultraviolet Rays; Vascular Diseases | 1970 |
Intravascular coagulation in acute hepatic failure.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Fibrinolysis; Heparin; Humans; Liver Diseases | 1970 |
Simultaneous fibrinogen and platelet survival with (75Se)selenomethionine in man. Studies in diseases with normal coagulation and in hepatocellular disease with abnormal coagulation.
Topics: Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinolysis; Hemolysis; Humans; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Radioisotopes; Selenium | 1970 |
Coagulation changes during massive hepatic necrosis due to Amanita phalloides poisoning with special reference to antihemophilic globulin.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Blood Proteins; Child; Child, Preschool; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Female; Fibrinogen; Fibrinolysis; Humans; L-Lactate Dehydrogenase; Liver Diseases; Male; Mushroom Poisoning; Necrosis; Prothrombin; Prothrombin Time | 1970 |
Clinical significance of plasma protein concentration.
Topics: Age Factors; Animals; Antigens; Blood Proteins; Cats; Cattle; Dehydration; Dog Diseases; Dogs; Female; Fibrinogen; Liver Diseases; Male; Optics and Photonics; Serum Albumin; Serum Globulins; Splenic Diseases | 1970 |
Septicemia as a manifestation of acute liver failure.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Fibrinogen; Hepatectomy; Liver Diseases; Macrophages; Neomycin; Phagocytosis; Preoperative Care; Pulse; Sepsis; Time Factors | 1971 |
Mechanisms of acquired defects of the stabilization of fibrin.
Topics: Adsorption; Aluminum Silicates; Blood Coagulation Disorders; Dialysis; Factor XIII; Fibrinogen; Hot Temperature; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Liver Diseases; Necrosis | 1971 |
[Coagulation studies in liver diseases of children].
Topics: Adolescent; Alkaline Phosphatase; Bile Ducts; Bilirubin; Blood Coagulation Tests; Child; Child, Preschool; Factor V; Factor VII; Factor X; Fibrinogen; Gallbladder Diseases; Hepatitis A; Hepatolenticular Degeneration; Humans; Infant; Liver Cirrhosis; Liver Diseases; Prothrombin Time; Transaminases | 1968 |
Active and potentially active forms of fibrin stabilizing factor (factor 13) in various disorders and in neonatal infants.
Topics: Blood Coagulation Factors; Child; Child, Preschool; Cysteine; Factor XIII; Fibrinogen; Glutathione; Humans; Infant, Newborn; Liver Diseases | 1968 |
Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
Topics: Acetates; Adolescent; Adult; Age Factors; Aged; Blood Coagulation Factors; Calcium; Factor XIII; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Thrombin; Time Factors | 1969 |
Some clinical biochemical methods used for the diagnosis of liver disease, especially in psychiatric cases (delirium tremens and after treatment with potentially hepatotoxic drugs).
Topics: Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Chemistry, Clinical; Cholinesterases; Clinical Enzyme Tests; Diagnosis, Differential; Fibrinogen; Fructose-Bisphosphate Aldolase; Humans; Isocitrate Dehydrogenase; Isoenzymes; L-Lactate Dehydrogenase; Liver Diseases; Ornithine Carbamoyltransferase; Prochlorperazine; Psychoses, Alcoholic | 1966 |